Podcasts about all england club

Join 4-time Grand Slam champion Kim Clijsters and tennis reporter Blair Henley as they recap Wimbledon, celebrate champions Jannik Sinner and Linda Nosková, and explore why Czech tennis continues to produce Grand Slam winners. Kim also shares behind-the-scenes stories from the Wimbledon Champions' Ball, returning to the All England Club, and experiencing the tournament from a new perspective after retirement. They also break down the WTA Finals move to Indian Wells, the ATP's proposed doubles overhaul, Roger Federer's upcoming Hall of Fame induction, Tatjana Maria's grass-court success, and Kim's tactical analysis of Aryna Sabalenka and Iga Świątek. Plus, hear why Kim believes Czech coaching remains one of the biggest keys to sustained success in tennis. Welcome to Love All! If you want to hang out with us behind the scenes follow us on all of our socials: https://www.instagram.com/loveallpodcast/ https://www.tiktok.com/@loveallpodcast  https://x.com/loveallpodcast  Kim's Rec: https://www.instagram.com/longevitylabkauai/  Blair's Rec: https://www.sephora.com/product/cay-skin-isle-lip-balm-spf-30-P481367?skuId=2561868  ⏰ TIMESTAMPS:  00:00 Welcome Back to Love All 01:50 Kim Reflects on Returning to Wimbledon 04:36 Blair's Hall of Fame Open Recap & Tatjana Maria's Grass Success 08:19 Roger Federer's Hall of Fame Induction Preview 09:44 What the Wimbledon Champions' Ball Is Really Like 13:10 Henley's Headlines: WTA Finals Move to Indian Wells 16:25 ATP's Doubles Overhaul Sparks Debate 25:06 Sabalenka & Świątek's Recent Struggles 34:37 Kimformation: Why Czech Tennis Produces So Many Champions 43:33 Kim Breaks Down Coco Gauff's Missed Match Point 49:36 Rec Room 52:47 Closing Thoughts Learn more about your ad choices. Visit megaphone.fm/adchoices

Our 2026 Wimbledon review breaks down the tournament results with expert Steve Flink. See how the champions secured their titles.Join Falzan and tennis analyst Steve Flink for a comprehensive look back at two weeks of intense competition at the All England Club. We examine the critical moments that defined the championships and discuss the standout performances that dominated the grass courts this year.This 2026 Wimbledon review focuses specifically on the paths taken by Jannik Sinner and Linda Noskova to lift their respective trophies. Whether you are catching up on the results or looking for a deeper tennis post-match analysis of the key upsets and momentum shifts, this conversation provides the context behind the headlines.Subscribe for weekly tennis breakdowns and let us know in the comments which 2026 Wimbledon match was your personal highlight.Timestamps:Intro 00:00Women's 00:59Men's 48:23Discount Affiliate Links:- Mantis 10%: https://mantissport.com/qualityshot10 (At Checkout)- IM8 10% OFF: https://im8.go2cloud.org/aff_c?offer_id=26&aff_id=2077 (Code QST10 at Checkout)- Acemate: https://www.acematetennis.com?sca_ref=11586466.udoQ3GLV6m55xoG1&utm_source=uppromote&utm_medium=referral&utm_campaign=standard-affiliate-commission&utm_content=affiliate-QualityShot-Tennis---Copyright Disclaimer: Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use and no copyright infringement is intended. No match footage is shown in these videos.

Linda Noskova is your Wimbledon champion, the 3rd Czech woman in 4 years! Her imposing power, resilience, and capable hands pushed her past Karolina Muchova, who managed to save 5 championship points in the second set but couldn't stem the tide. Jannik Sinner defends his title, rarely summoning his best but doing enough to beat an inspired That Guy and prevent what would have been a cursed and vexatious Channel Slam. In doubles, Patten takes aim at the ATP in his victory speech, Ostapenko gets blamed for something she didn't do (for once), and Guo/Mladenovic knock out the top seeds and eventually win the title. We also chat about Czech tennis history and the everlasting effort to identify why they're so good, plus the decades-long saga of the All England Club's plans to expand its site and what still stands in the way.  0:40 Linda Noskova wins Wimbledon at 21 7:45 My ex-friend 10:15 Other notes from women's second week: Gauff-Muchova and more 16:55 What's the deal with Czech tennis? 23:00 Jannik Sinner averts disaster, but the Monster has already been created 34:35 What's next for Novak? 38:35 Henry Patten takes on the ATP + other doubles results 44:45 Wimbledon expansion: locals say Not On My Church Road

Tapt Media's tennis correspondent Craig Gabriel reports from the All England Club, where Jannick Sinner has defeated Alexander Zverev in the men's final.See omnystudio.com/listener for privacy information.

Tapt Media's tennis correspondent Craig Gabriel reports from the All England Club, where Jannick Sinner has defeated Alexander Zverev in the men's final.See omnystudio.com/listener for privacy information.

Tapt Media's tennis correspondent Craig Gabriel reports from the All England Club, where Jannick Sinner has defeated Alexander Zverev in the men's final.See omnystudio.com/listener for privacy information.

A look ahead at Championship weekend at Wimbledon. Novak Djokovic can't keep momentum after the longest QF in Wimbledon history as Sinner looks to win back-to-back titles at the All England Club. On the women's side it's Karolina Muchova vs. Linda Noskova. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

TennisNow writer Chris Oddo joins the podcast to dive into the final push at the 2026 Wimbledon Championships, where everything is on the line for those remaining in the field. Oddo recaps Karolina Muchova's emotional win over Coco Gauff to reach the finals, and explains how the dynamic player was able to conquer a foe who has given her nothing but problems. The journalist also breaks down how Linda Noskova topped Marta Kostyuk in the other semifinal, and highlights the special skills that make the 21-year old one a threat to everyone on the grass. And Oddo points out what to expect from an all Czech championship match in London. On the men's side, it's another showdown between Novak Djokovic and Jannik Sinner in a major semifinal. Oddo reacts to Djokovic's marathon win over Felix Auger-Aliassime, and ponders how the Serbian legend will be feeling physically in the next round. The writer dives into Sinner's level this Wimbledon, his road to success on the grass, and the keys that will determine this epic encounter between two titans in tennis. Oddo also shares his thoughts on Alexander Zverev's ability to carry over success from Roland Garros to Wimbledon, British Wild Card Arthur Ferry's improbable run to the Final 4, and how the dust might settle on championship Sunday at The All England Club. Hosted by Mitch Michals. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Alexander Zverev et Arthur Fery s'offrent un rendez-vous avec l'histoire. C'est le choc des mondes : le vainqueur du Grand Chelem parisien face au gamin de Londres !Dans cette émission on analyse les deux performances monumentales qui ont validé cette affiche irréelle en demi-finale de Wimbledon.D'un côté, Alexander Zverev qui, face à sa bête noire Taylor Fritz, a été d'un sérieux clinique : 3 petits sets (6-4, 6-4, 6-2) pour chasser ses démons, s'éviter un piège mental et s'offrir sa toute première demi-finale au All England Club. Zverev libéré ? Pourquoi sa victoire contre Fritz prouve qu'il a enfin trouvé la clé sur gazon ?De l'autre côté du filet, Arthur Fery, invité du tournoi, qui a une nouvelle fois surclassé Flavio Cobolli devant un Centre Court en transe. Il devient le deuxième wildcard de l'histoire à atteindre ce stade après un certain Goran Ivanisevic en 2001... Comment ce gamin, porté par tout un peuple, a pu détruire la tête de série numéro 9 avec autant d'assurance tactique ?On fait aussi un gros point sur le tableau féminin avec les qualifications impressionnantes de Marta Kostyuk et Linda Noskova sans oublier les pronostics sur le dernier carré WTA. Muchova vs Gauff et Kostyuk vs Noskova, qui décrochera sa place en finale ?Ce podcast est hébergé par Podcastics, la plateforme pour créer et diffuser votre podcast facilement.

Andy Roddick and Jon Wertheim break down Day 10 at Wimbledon, from Arthur Fery's unbelievable home-soil fairytale and Alexander Zverev's semifinal run to Coco Gauff's growing confidence on grass and the fascinating women's semifinal matchups. They analyze why variety is thriving at Wimbledon, debate who has the edge heading into Championship Weekend, explain what makes Fery's run historically unique, and share behind-the-scenes stories from the All England Club. COMMENT BELOW: What was your favorite match of Day 10?

Tapt Media's Tennis Correspondent Craig Gabriel reports from Wimbledon where Alexander Zverev has beaten an injured Taylor Fritz in straight sets to make it through to the semis at the All England Club. See omnystudio.com/listener for privacy information.

Tapt Media's Tennis Correspondent Craig Gabriel reports from Wimbledon where Alexander Zverev has beaten an injured Taylor Fritz in straight sets to make it through to the semis at the All England Club. See omnystudio.com/listener for privacy information.

Tapt Media's Tennis Correspondent Craig Gabriel reports from Wimbledon where Alexander Zverev has beaten an injured Taylor Fritz in straight sets to make it through to the semis at the All England Club. See omnystudio.com/listener for privacy information.

In this episode I look at the Wimbledon quarterfinals & what's led to this point. The biggest storylines at the All England Club in the first week of Wimbledon. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Alexandra Stevenson joins the show to breakdown all the drama at Wmbledon, where we will crown a different women's champion for the 10th straight year. Stevenson recaps Naomi Osaka's impressive win over Aryna Sabalenka, and explains how the Japanese superstar has returned to her top form. The former Wimbledon semifinalist also looks at a pending showdown between Americans Jessica Pegula and Coco Gauff, and dives into where each player has as advantage on the grass. Stevenson shares her thoughts on Karolina Muchova's style of play, Marta Kostyuk's athleticism, and how Linda Noskova has leveled up in 2026. On the men's side, Stevenson shares her thoughts on Novak Djokovic's sustained brilliance at 39 years old. The former pro examines whether Felix Auger-Aliassime can challenge the Serbian legend, and whether Jannik Sinner can reach his top gear at these Wimbledon championships. And Stevenson assesses Taylor Fritz's chances to go all the way at The All England Club or if Alexander Zverev, Flavio Cobolli or British Wild Card Arthur Ferry can keep their Wimbledon dreams alive. Hosted by Mitch Michals. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Explore Wimbledon 2026 Round of 16 betting insights and odds predictions with expert analysis from Sean Calvert and Nigel Seeley. The handicappers provide their betting strategies, best bets, and value plays for Monday's top matches at the All England Club. 00:00 Monday Round Of 16 Previews 03:36 Alexander Zverev vs. Jiri Lehecka 11:18 Alex De Minaur vs. Flavio Cobolli 17:12 Grigor Dimitrov vs. Arthus Fery 24:20 Taylor Fritz vs. Alexander Bublik

Tapt Media's tennis correspondent Craig Gabriel reports from Wimbledon where Novak Djokovic has secured his 106th men's match win at the All England Club. See omnystudio.com/listener for privacy information.

Tapt Media's tennis correspondent Craig Gabriel reports from Wimbledon where Novak Djokovic has secured his 106th men's match win at the All England Club. See omnystudio.com/listener for privacy information.

Tapt Media's tennis correspondent Craig Gabriel reports from Wimbledon where Novak Djokovic has secured his 106th men's match win at the All England Club. See omnystudio.com/listener for privacy information.

On July 5, 2026, Novak Djokovic triumphed over Roman Safiullin with a score of 7-6(6), 6-3, 3-6, 6-3 at Wimbledon, thereby advancing to his 17th quarter-final.This intense four-set match lasted three hours and 25 minutes on a scorching Centre Court. With this win, Djokovic eclipsed Roger Federer's all-time men's record by achieving his 106th singles victory at the All England Club.He accomplished his 106th win, surpassing Roger Federer's previous record of 105 victories. He now ranks second only to Martina Navratilova, who holds 120 wins on the all-time list, and has reached his 66th career Grand Slam quarter-final out of 83 major tournaments, further extending his own historical record. At the age of 39, he became the third man in the Open Era to reach the Wimbledon quarter-finals at 39 or older, joining the ranks of Ken Rosewall and Federer. He has also maintained an impeccable 34-0 career record against qualifiers in Grand Slam events.Djokovic is on course to pursue a record-breaking 25th Grand Slam singles title and to match Federer's tally of eight Wimbledon championships. He will compete in the quarter-finals on Tuesday, July 7, against either third seed Felix Auger-Aliassime or 22nd seed Alejandro Davidovich Fokina.

This episode of The Times Tech Podcast is in paid partnership with IBM.Wimbledon may be one of the most familiar events in British sport, but behind the tennis is a vast technology operation – from live match data and digital storytelling to AI tools designed to help fans follow the Championships in real time.Katie Prescott is joined by Kameryn Stanhouse, Vice President of Sports and Entertainment Partnerships at IBM, and Chris Clements, Senior Manager of Digital Strategy and Products at the All England Club, to discuss how technology is changing the Wimbledon experience, both on the grounds and for fans around the world.Image: Getty Hosted on Acast. See acast.com/privacy for more information.

Hall of Famer journalist Steve Flink returns to the podcast to break down all the action at Wimbledon, where the tennis is supreme at The All England Club. Flink assesses the early performances of Jannik Sinner and Novak Djokovic, and laments on Ben Shelton's shocking upset loss. The writer discusses Taylor Fritz's chances to make a run at the title, Grigor Dimitrov's surprising win, and his appreciation for Daniil Medvedev's raw honesty in defeat. Flink goes in depth about the women's draw, where Naomi Osaka is playing some elite tennis. The journalists weighs her chances against World No. 1 Aryna Sabalenka, and looks at whether Sabalenka and Rybakina can return to their apex as the tournament progresses. And Flink looks at some of the great matches on tap, which include Iga Swiatek vs Alexandra Eala, Jessica Pegula vs. Iva Jovic, and Dimitrov vs. former Wimbledon finalist Matteo Berrettini. Hosted by Mitch Michals. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Great news! If you make a purchase from any link of the links below, the channel earns a small affiliate commission from the site. Many thanks ahead of time. BETTER HELP: https://www.betterhelp.com/JAYREELZ save 10% OFF of your first month. OLIPOP Soda: https://www.drinkolipop.com use promo code JAYREELZ for 15% off of your purchase. BOMBA SOCKS: https://www.gopjn.com/t/2-561785-354075-142593 SAVE 20% CONSUMER CELLULAR: https://www.pntrs.com/t/2-593611-354075-293459 July has arrived with sweltering heat, which is what I'll provide with all that's going on in the sports world as the latest podcast is here. On deck: (5:04) You couldn't ask for a more crazier start to the NBA free agency period. In fact, the trades have made the biggest impact the last few days. From Ja Morant getting sent to Portland, Kawhi Leonard going back to Toronto and the inexplicable Jaylen Brown to Philadelphia. I'll break it all down and where should LeBron James end up as he's part ways with the Lakers. (32:43) The USA Men's Soccer Team advances to the next match against a hot opponent in Belgium. Their win over Bosnia-Herzegovina was costly and controversial. I'll explain why and get into Belgium's huge comeback win, Mexico's incredible run and the schedule for the weekend as we get closer to the quarterfinals of the World Cup. (49:14) We can't forget the NHL is going through their free agency period as well. I'll take a peek at some key signings and how Utah, San Jose and Florida have come out of the gate swinging with big time moves.  (59:27) June couldn't finish any faster if you're the Yankees, but July isn't off to a good start either. I'll get into the annual June Boone Swoon, how they've lost seven in a row and will they get out of this funk sooner than later? Also, Mets owner Steve Cohen had a thing or two to say about his GM David Stearns. Cover your ears, Mets fans. It's not looking good. (1:11:18) Serena Williams made a nice return to the Wimbledon stage, but it didn't last long as she lost in three sets to Maya Joint. I'll check in on what else is happening at the All England Club as the weekend approaches.  And MUCH MORE in between! Please subscribe, leave a rating and post a review on Apple Podcasts, Google Podcasts, Spotify, Audacy, Amazon Music and iHeartRadio or wherever you get your podcasts. For daily shorts, weekly vlogs and then some, please subscribe to my YouTube channel at: https://www.youtube.com/channel/UCMucZq-BQrUrpuQzQ-jYF7w If you'd like to contribute to the production of the podcast, please visit my Patreon page at: www.patreon.com/TheJAYREELZPodcast   Many thanks for all of your love and support.   Intro/outro music by Cyklonus. LINKS TO SUBSCRIBE, RATE & REVIEW: APPLE: https://podcasts.apple.com/us/podcast/the-jayreelz-podcast/id1354797894 SPOTIFY: https://open.spotify.com/show/7jtCQwuPOg334jmZ0xiA2D?si=22c9a582ef7a4566 AUDACY: https://www.audacy.com/podcast/the-jayreelz-podcast-d9f50 iHEARTRADIO: https://www.iheart.com/podcast/256-the-jayreelz-podcast-43104270/ AMAZON MUSIC: https://www.amazon.com/The-JAYREELZ-Podcast/dp/B08K58SW24/ref=sr_1_1?dchild=1&keywords=the+jayreelz+podcast&qid=1606319520&sr=8-1

Andy Roddick and Jon Wertheim recap Wimbledon Day 2, breaking down Serena Williams' long-awaited singles return, Ben Shelton's shocking first-round exit, and what both results mean moving forward. They also discuss Taylor Fritz's title chances, Iga Swiatek's emotional victory, Stan Wawrinka's remarkable longevity, and the biggest storylines unfolding at the All England Club. COMMENT BELOW: What was your favorite match of Day 2?

Wimbledon 2026 continues on Thursday with more Gentlemen's Second Round matches at the All England Club. Sean Calvert and Nigel Seeley link up to preview the betting angles, trends, and odds changes for noteworthy matches. The tennis handicappers explain their betting strategies and offer up best bets and value plays. 00:00 Sean is heading to Wimbledon 04:04 Quentin Halys vs. Marcos Giron 09:16 Arthur Fils vs. Matteo Berrettini 15:34 Gabriel Diallo vs. Lorenzo Sonego 19:46 Alex De Minaur vs. Adrian Mannarino

It's In the News - a look at the top diabetes headlines and stories happening now. Our top stories: More information about type 1 and COVID, including the vaccine, why is the latest GLP-1 medication, not yet FDA approved, showing up all over the place, what table sugar and vinegar could mean for drug costs, a new inhaled insulin study and much more  I'll see you at Friends for Life next week. Come find me at Table T18 Learn more about our in-person events here: https://diabetes-connections.com/events/ Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Transcript & links:    Okay.. our top story this week: XX A large Swedish study found that the increased risk of being diagnosed with type 1 diabetes after COVID-19 infection is mostly limited to the first 30 days after infection and does not continue long term. Researchers followed nearly the entire Swedish population under age 80 from 2020 through 2023 and found that while SARS-CoV-2 infection was linked to a temporary rise in new type 1 diabetes diagnoses, the risk declined over time. The study also found no evidence that COVID-19 vaccination increases the long-term risk of developing type 1 diabetes. Vaccination did not significantly change the relationship between COVID-19 infection and diabetes risk, and any small increase in diagnoses seen among adults shortly after a first vaccine dose was not seen after later doses or during longer follow-up. The researchers concluded that their findings do not support changing current COVID-19 vaccination recommendations because of concerns about type 1 diabetes risk. https://www.infectiousdiseaseadvisor.com/news/covid19-infection-may-increase-short-term-type-1-diabetes-risk/ XX Two new studies are challenging the traditional view that type 1 diabetes develops solely because the immune system attacks insulin-producing beta cells. Researchers from Indiana University found evidence that beta cells themselves may play an active role in determining whether they survive or succumb to the stresses that lead to type 1 diabetes. In the first study, scientists discovered that some healthy human beta cells can quickly activate an antiviral defense system when exposed to interferon-alpha, an immune signal often produced during viral infections. This response relies on molecules called reactive oxygen species (ROS), which are usually associated with cell damage but, in this case, appeared to help switch on protective antiviral genes. Researchers found this defense program in healthy cells and in people at risk for type 1 diabetes, but not in beta cells from people who already had the disease. The findings suggest that losing this built-in defense mechanism may make beta cells more vulnerable during the development of type 1 diabetes. The second study focused on autophagy, the process cells use to recycle damaged or worn-out components. Using a new imaging technique, researchers observed that beta cells in a mouse model of type 1 diabetes showed defects in autophagy before blood sugar levels began to rise and even before a full immune attack was underway. This suggests that problems inside the beta cells may occur early in the disease process rather than being caused entirely by the immune system. Together, the studies point to a more complex picture of type 1 diabetes. While they do not show that beta-cell defects cause the disease, they suggest that differences in how beta cells respond to stress, viral signals, and cellular damage may influence who develops type 1 diabetes and how the disease progresses. https://medicalxpress.com/news/2026-06-beta-cells-players-diabetes.html XX Researchers have created the most detailed map yet of how the human pancreas develops during childhood, offering new clues about why children are especially vulnerable to developing diabetes. The study, published in Nature Communications, examined pancreatic tissue from 123 children without diabetes, ranging from newborns through age 10. Using advanced imaging techniques, scientists tracked how insulin-producing islet cells grow and mature during the first decade of life. The researchers found that pancreas size varies dramatically at birth, with some infants having pancreases nearly four times larger than others. They also discovered that insulin-producing beta cells grow more slowly after birth than previously thought, suggesting that much of a person's lifelong beta cell capacity may be established before birth and during early childhood. Other findings showed that insulin-producing cells mature earlier than glucagon-producing cells and that new hormone-producing cells may continue to form after birth. The researchers hope this new understanding of pancreas development will help scientists identify diabetes risk earlier and develop better strategies for prevention and treatment in children. https://news.vumc.org/2026/06/29/unlocking-diabetes-secrets-pediatric-organ-donors-help-map-a-path-to-a-cure-and-prevention/   XX At the American Diabetes Association annual meeting, 2-year results from the SUPPRESS-EARLY trial showed that initiating tirzepatide (Mounjaro, Zepbound) early in the course of type 2 diabetes led to substantially higher rates of near-normal glycemic control and also led to broader metabolic improvements compared with intensive conventional therapy.   In this MedPage Today video, investigator Stefano Del Prato, MD, of the University of Pisa in Italy, discusses the findings.     Following is a transcript of his remarks:   What happened is that in the tirzepatide-treated arm, 85% of the population at the end of the second year was on the maximum dose of tirzepatide 15 mg. And then the remaining 15 with the different doses.   Interestingly, in the population that had been treated with the intensive conventional approach, 85% of them ended up to have, on top of metformin, a GLP-1 receptor agonist, mainly represented by subcutaneous semaglutide [Ozempic, Wegovy], 60+%, another 15% on oral semaglutide [Rybelsus], and the remaining on dulaglutide [Trulicity].   And I have to say that maybe the recommendation to really push along the line to try to achieve and to strive to achieve [glycemic] control was successful in these individuals. Because the population that had been recruited in the study started off with a baseline A1C of 7.8% and it went down to 6.3% in the conventionally intensive treatment, which is not bad at all, on average is below the target of 6.5%.     However, when we look at the effect of tirzepatide, the final level of A1C at the end of the second year was 5.6%, which is on average below the upper limit of the normal range for A1C, 5.7%. This also translates into more people not only achieving normal glycemia, if we can define normal glycemia as A1C below 5.7%, greater than what we observed in conventionally treated individuals. So it was around three times more people achieving an A1C of 5.7%, in the range of around 65%, as compared to 28% with people on a conventional optimized treatment.   Now, this is not surprising knowing the potency of tirzepatide. But again, going back to the rationale of the design, can we change what is the natural history of the disease? This seems to be at least of interest and it's possibly changing the trajectory of the disease for glycemic control, as I mentioned, but also in terms of the body weight and waist circumference because both body weight and waist circumference went much lower with tirzepatide compared to the conventional treatment.   Tirzepatide also was associated with an improvement in the lipid profile, in particular with the LDL, triglycerides, and the triglyceride concentration and non-HDL cholesterol, and also with a statistically significantly lower systolic blood pressure with a numerical reduction in the diastolic blood pressure.   And also the other thing that probably will ... become more apparent with the study continuing is that the investigators were allowed to add on any other treatment ... needed to achieve their target. So tirzepatide was just metformin and tirzepatide. In the control group, there was already 10% of people who were receiving two drugs on top of the metformin.   So another potential result of the trial is that it's possible to achieve and maintain better glycemic or better metabolic control over the time without really needing to increase the number of medications in order to achieve that goal. And we know that type 2 diabetes is a progressive condition often requiring intensification of the treatment.   So these initial results really stand for a great opportunity with tirzepatide. Of course, we need to wait for the 4 years just to confirm that this is indeed the case, but the initial result seems to point along that line. https://www.medpagetoday.com/meetingcoverage/adavideopearls/121967 XX A study from the University of Virginia found that high blood pressure is extremely common among people with diabetes, even among those who believe their blood pressure is under control. Researchers measured blood pressure in 172 adults with type 1 or type 2 diabetes during routine eye clinic visits and found that only 8% had normal readings. About half had stage 2 hypertension, and more than 10% had blood pressure levels high enough to be considered a medical emergency. The study also revealed that many patients were unaware of how serious their blood pressure problems were. Among those who thought their hypertension was well controlled, more than half still had stage 2 hypertension. Nearly 60% of participants were advised to contact their primary care provider, and one patient required an emergency department referral. Most patients supported blood pressure screening during eye exams, leading researchers to suggest that routine blood pressure checks in ophthalmology clinics could help identify undiagnosed or poorly controlled hypertension before it leads to serious complications such as heart attack, stroke, or worsening diabetic eye disease. https://medicalxpress.com/news/2026-06-routine-eye-exams-reveal-stage.html XX What is going on with retatrutide? This is the next generation GLP-1 but it's not authorized outside of clinical trials. Big investigation by CBS shows retatrutide is for sale all over the internet, a phenomenon they say has no modern precedent. CBS News identified more than 120 websites selling or promoting retatrutide, including more than 50 clinics staffed by licensed medical professionals. After being contacted by CBS News, at least 21 clinics abruptly removed retatrutide from their websites or changed the language to state they don't offer it. Others defended prescribing it, saying they're confident enough in results from clinical trials sponsored by drugmaker Eli Lilly that they didn't need to wait for the FDA's independent, rigorous review. An FDA spokesperson said retatrutide "has not been found safe or effective for any condition," adding that it "cannot be manufactured or distributed except for investigational use." The Justice Department is prosecuting two cases – in Utah and Florida – involving the sale and prescription of retatrutide. But the first line of enforcement is often at the state level. Ohio's Board of Pharmacy has taken action against several pharmacies and clinics providing retatrutide, and just last month, Alabama's Medical Board warned physicians against prescribing research-grade medications. The FDA has sent 14 warning letters to companies that have advertised retatrutide since 2024. Of these, at least six have continued to offer it online, including a business called Pink Pony Peptides. A TikTok account associated with the firm responded to the warning in April by taunting the FDA, boasting that the business "just had the best 24 hours ever." In May, Eli Lilly announced that participants in a large clinical trial taking the highest dose of retatrutide lost an average of 28% of their body weight over 80 weeks. Side effects – including nausea, diarrhea, constipation and vomiting – were comparable to similar therapies, the company said. "Anyone purporting to sell retatrutide to consumers is breaking the law," an Eli Lilly spokesperson said https://www.cbsnews.com/projects/2026/experimental-weight-loss-drug/ XX Pioneering research has developed a new way of creating carbohydrate-based medicines, which could ultimately replace costly drugs for common health conditions, using two cheap basic ingredients – table sugar and vinegar. These medications include SGLT2 inhibitors, widely prescribed drugs used to treat type 2 diabetes, heart failure and chronic kidney disease. Co-lead author Professor Phil Baran, Dr. Richard A. Lerner Endowed Chair at Scripps Research, in San Diego, California, said: "The point of this is to show that anyone in a garage can make an SGLT2 inhibitor with reagents that are widely available. We have not patented this method, so we welcome any generic drug company – or anyone else – who wants to use it to help bring costs down for patients." https://www.newswise.com/articles/new-study-shows-table-sugar-could-hold-a-cheaper-quicker-key-to-making-vital-drugs-for-diabetes-heart-failure-and-chronic-kidney-disease XX England and Wales approve teplizumab to slow progression of T1D. At the moment, the Scottish Medicines Consortium does not have an appraisal of Tzield on the go, so, there is likely to be a disparity in access within the UK for the time being. In Northern Ireland, access will depend on a review and adoption of NICE guidance.  Sanofi is expecting to see an uptick in momentum thanks to two subsequent FDA approvals, one in children as young as one with stage 2 T1D, and a second to delay the decline in endogenous insulin production in children aged eight to 17 years recently diagnosed with stage 3 T1D. btw you might here more people referring to stage 4 diabetes. They've added that to include people diagnosed with type 1 who've been on insulin for a longer period of time – basically long enough to not be eligible for the current guidelines for Tzield. https://www.bbc.com/news/articles/ce8mzd94r76oXX XX Obesity Association, a division of the American Diabetes Association® (the association), announced the next section in the Standards of Care in Overweight and Obesity, "Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults," published in Diabetes, Obesity, and CardioMetabolic CARE® and BMJ Open Diabetes Research & Care.  Key highlights of the guidance: Early screening: Annual BMI screening with emphasis on tracking weight trends to identify risk earlier, including a longitudinal life-event weight graph tool for standardized assessment. Enhanced diagnosis: Combines BMI with waist measurements and population-specific thresholds to improve accuracy. Notably, the guidelines recommend that BMI in the overweight range together with central adiposity measurements warrant a formal obesity diagnosis. Comprehensive evaluation: Holistic assessment including medical, behavioral, and social factors. Offers a fully integrated obesity diagnostic algorithm. Risk stratification: Use of tools like the Edmonton Obesity Staging System to guide care. Chronic care approach: Ongoing monitoring and follow-up to support long-term management. Reducing bias: Promotes person-centered, non-stigmatizing care and system-level improvements at the clinical workflow level and encourages screening for prior weight bias/stigma experiences. https://www.prnewswire.com/news-releases/new-standards-of-care-in-overweight-and-obesity-section-screening-diagnosis-evaluation-and-staging-of-obesity-in-adults-302809670.html XX Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience. San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. Dexcom said its reimagined app aims to make glucose insights easier to understand and act on. It hopes to help build awareness of how food, activity, sleep and stress influence overall wellbeing.   The company also reiterated plans to launch Stelo internationally. It expects to bring the sensor to the UK, Australia, New Zealand and South Korea later this year, continuing into 2027. https://www.drugdeliverybusiness.com/dexcom-launches-enhanced-stelo-app/ XX MannKind Corporation recently announced it received a grant from Breakthrough T1D to support the INHALE-1 clinical study of Afrezza, its ultra rapid-acting inhaled insulin, in newly diagnosed pediatric type 1 diabetes patients aged 10 to under 18 years. This external funding for a trial focused on early use of Afrezza in children highlights growing third-party support for inhaled insulin in pediatric diabetes care. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mnkd/mannkind/news/afrezza-pediatric-trial-grant-might-change-the-case-for-inve XX Alexander Zverev heads into Wimbledon with plenty of momentum. The French Open champion returns to the All England Club looking to build on his first Grand Slam title and gain ground on Carlos Alcaraz in the race for the No. 2 spot in the ATP rankings. Zverev has an opportunity to make up points quickly after a first-round exit at Wimbledon last year. But his final tune-up before Wimbledon came with an unexpected challenge. During his semifinal loss to Taylor Fritz at the Halle Open, Zverev said a malfunctioning glucose sensor led to serious diabetes management issues on court. The sensor incorrectly showed his blood sugar was high when it was actually low, causing him to take more insulin than needed. "I had huge problems with the sugar because the sensor I use gave me a completely incorrect reading," Zverev said after the match. "During the match, or rather during the first 45 minutes, I had to consume about 350 grams of sugar. I felt absolutely terrible." Despite feeling unwell, Zverev pushed the match to three sets before falling 6-7(4), 6-4, 7-5 to Fritz. He credited his opponent with playing the better match and said the diabetes-related issue was not an excuse for the result. Zverev, who was diagnosed with type 1 diabetes at age 4, uses Medtronic diabetes technology to help manage his glucose levels while competing on the ATP Tour. He said the sensor error was the first major problem he has experienced after nearly a decade of using the technology. The German said the incident should not affect his Wimbledon preparations. With the sensor issue behind him, Zverev will begin his Wimbledon campaign focused on adding another strong result to what has already been a breakthrough season.   https://www.reuters.com/sports/tennis/zverev-says-glucose-sensor-malfunction-affected-halle-semi-final-loss-fritz-2026-06-21/

VSIN tennis writer and podcast host Zachary Cohen joins the show to dive into all the action from Day 1 at Wimbledon, where the top two men's favorites dug deep to advance. Cohen recaps the gritty wins by Jannik Sinner and Novak Djokovic, and analyzes their paths to glory at The All England Club. The journalist weights in on the American male hopefuls, Joao Fonseca's grass potential, and Alexander Zverev's first major act since winning Roland Garros. Cohen also debates which women are legitimate Wimbledon contenders, and explains why this could be Jessica Pegula's time to capture a slam title. He looks at Aryna Sabalenka's hurdles in London, Coco Gauff and Iga Swiatek's chances, and whether Mirra Andreeva can pick up right where she left off in Paris. And Cohen makes some predictions about who will be standing tall when the dust settles at The Wimbledon Championships. Hosted by Mitch Michals. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

It's on to Second Round matches at Wimbledon 2026. Sean Calvert and Nigel Seeley preview the betting angles and make their predictions for key Wednesday matches at the All England Club. The tennis handicappers analyze the trends, examine weather conditions, and detail their betting strategies to provide you with the best bets and value plays. 00:00 Wimbledon 2026 First Round Recap 06:08 Roman Safiullin vs. Botic Van de Zandschlup 12:37 Jenson Brooksby vs. Ignacio Buse 17:44 Arthur Rinderknech vs. Martin Damm 22:55 Hubert Hurkacz vs. Sebastian Ofner

Osaka is renowned for turning heads with her on-court outfits, but making them compatible with Wimbledon's strict dress code required some special inspiration. Japan's four-time major winner paid tribute to her country's culture by arriving for her opening match at the All England Club in an elegant, full-length kimono. The ensemble was entirely white to comply with the tournament's rules.

Great news! If you make a purchase from any link of the links below, the channel earns a small affiliate commission from the site. Many thanks ahead of time. BETTER HELP: https://www.betterhelp.com/JAYREELZ save 10% OFF of your first month. OLIPOP Soda: https://www.drinkolipop.com use promo code JAYREELZ for 15% off of your purchase. BOMBA SOCKS: https://www.gopjn.com/t/2-561785-354075-142593 SAVE 20% CONSUMER CELLULAR: https://www.pntrs.com/t/2-593611-354075-293459 June closes out the first half of 2026 strong with an action packed sports podcast that any fan will get excited for. On deck: (3:49) Who said Christmas is the most wonderful time of the year. It's about to heat up in the Northeast as temperatures will reach 100 by the end of the week, so you know I'm looking forward to that. (4:50) We're already at the halfway point of the MLB season. What are some of the main takeaways over the first three months? (Phillies on the rise. Dodgers being the Dodgers. Is the AL up for grabs?) (28:07) The World Cup is now onto the round of 32. What can we possibly expect over the next week or so, especially with the US team after their lackluster performance against Turkey. (41:25) The Charlotte Hornets make their second big trade in a week, packaging Miles Bridges to Phoenix. Are they trying to undo the good fortune of last year? (48:42) There's plenty of wheeling and dealing in the NHL over the weekend. I'll recap the top draft stories in Buffalo, as well as, share which players will have new addresses next year. (56:53) Wimbledon is underway as the third tennis major has arrived. Is Serena Williams return a big story? I'll get into what I think we should watch out for (Jannik Sinner vs. the heat. Can Aryna Sabalenka rebound?) as the All England Club is set for two weeks of competitive play. And MUCH MORE in between! Please subscribe, leave a rating and post a review on Apple Podcasts, Google Podcasts, Spotify, Audacy, Amazon Music and iHeartRadio or wherever you get your podcasts. For daily shorts, weekly vlogs and then some, please subscribe to my YouTube channel at: https://www.youtube.com/channel/UCMucZq-BQrUrpuQzQ-jYF7w If you'd like to contribute to the production of the podcast, please visit my Patreon page at: www.patreon.com/TheJAYREELZPodcast   Many thanks for all of your love and support.   Intro/outro music by Cyklonus. LINKS TO SUBSCRIBE, RATE & REVIEW: APPLE: https://podcasts.apple.com/us/podcast/the-jayreelz-podcast/id1354797894 SPOTIFY: https://open.spotify.com/show/7jtCQwuPOg334jmZ0xiA2D?si=22c9a582ef7a4566 AUDACY: https://www.audacy.com/podcast/the-jayreelz-podcast-d9f50 iHEARTRADIO: https://www.iheart.com/podcast/256-the-jayreelz-podcast-43104270/ AMAZON MUSIC: https://www.amazon.com/The-JAYREELZ-Podcast/dp/B08K58SW24/ref=sr_1_1?dchild=1&keywords=the+jayreelz+podcast&qid=1606319520&sr=8-1

The Tennis Tragic #074 / Hello Upended Earth / Matte and David gather in advance of Wimbledon 2026 to discuss the state of the world, and how everything is forever changed. The Knicks won the championship. Zverev won a Major. Nothing will ever be the same. Also: Roger does a Tennis Tarot reading for the All-England Club, big things are predicted for Muchova and Eala, and big first titles are won by Robin Montgomery and Alejandro Davidovich Fokina. Finally, we debate the value of the question "What does [this victory] mean to you?" and grapple with Marketa Vondrousova's 4-year doping ban for a missed test, leading Matte to propose a socialist revolution.Visit the Tennis Tragic archive at www.tennistragic.comFollow us on Instagram @tennistragicpod

Wimbledon 2026 Day One - a day of withdrawals and not many wins for Great British Tennis. Michael and John are at the All England Club the day after Emma Raducanu pulled out and on the day Jack Draper also withdrew through ongoing injury concerns. We catch up with BBC commentators Nick Lester and Katie Smith on the fall out - and look ahead to the return of Serena Williams! Learn more about your ad choices. Visit podcastchoices.com/adchoices

The Wimbledon 2026 Women's First Round is set to begin, and Tim Dennis and Nigel Seeley are here to break down the betting angles, odds, tips and picks. Serena Williams makes her return to the All England Club and our tennis handicappers analyze the market and provide best bets on her match against Maya Joint, as well as other key First Round matches. 00:00 Wimbledon Women's First Round Match Previews 01:22 Wimbledon Conditions, Weather Updates 04:16 Ashlyn Krueger vs. Donna Vekic 08:48 Yulia Putintseva vs. Tatjana Maria 13:48 Serena Williams vs. Maya Joint 20:50 Tereza Valentova vs. Karolina Pliskova 24:14 Maria Sakkari vs. Clara Tauson 27:52 Jasmine Paolini vs. Robin Montgomery

The third tennis major heads to the All England Club, and Betting Weekly is here with your Wimbledon 2026 Men's preview. Tennis betting experts Sean Calvert and Nigel Seeley analyze the betting odds, and tournament draw to find value plays in the outright futures market. The handicappers examine the weather conditions, offer up match predictions, and detail players to watch as the tournament unfolds. 000:00 Gearing up for Wimbledon 2026 01:46 ATP Wimbledon 2026 Men's Preview 02:02 ATP Wimbledon 2026 Weather/Conditions 06:42 ATP Wimbledon 2026 Key Trends 08:50 Wimbledon Previous Winners 09:22 ATP Wimbledon 2026 Draw Breakdown 10:50 ATP Wimbledon 2026 Winner Futures

Wimbledon 2026 has arrived and Tim Dennis and Nigel Seeley are here to preview the odds, draw and every betting angle from the All England Club. The tennis handicappers analyze weather conditions, examine the futures market, and assess which players have the best paths to the semifinals. 00:00 Wimbledon is here 01:54 WTA Wimbledon 2026 Women's Preview 02:50 WTA Wimbledon 2026 Weather Conditions 03:12 WTA Wimbledon 2026 Key Trends 04:26 Previous Wimbledon Winners 05:26 WTA Wimbledon 2026 Draw Breakdown 07:26 WTA Wimbledon 2026 Winner Futures

Want to be featured on the next Q&Andy? Send us a video on our socials or email us at askandy@servedmediagroup.com Andy Roddick sits down with British tennis legend and All England Club board member Tim Henman for a look inside the most iconic tournament in the sport. As the tennis world turns its eyes to Wimbledon, Henman pulls back the curtain on the complex, behind-the-scenes decision-making at Wimbledon—from the controversial wildcard process for top stars and rising prospects to the delicate balance of maintaining 150 years of tradition while modernizing the grounds. The two discuss the reality of the grass-court season, including the impact of surface quality and equipment on the modern game, while reminiscing about their own high-pressure battles on Centre Court against legends like Pete Sampras.

Wimbledon 2026 Daily Pod: Andreescu, & Sawangkaew Win, Zheng And Virtanen Qualify! | Day 4

Hanlon Walsh joins the podcast to discuss the top storylines heading into a Wimbledon, with uncertainty reigning supreme among both tours. Walsh looks at the American men led by Ben Shelton and Taylor Fritz, and examines whether Tommy Paul and Frances Tiafoe can continue to thrive on the grass. The writer for Tennis Tribe discusses whether Aryna Sabalenka is poised for a bounce back at The All England Club, explains why he Jessica Pegula is ready to for a deep major run, and weighs in on Serena Williams' much-anticipated return alongside her sister Venus. Walsh also reflects on how he became a diehard tennis fan, and how that journey led him to becoming a very credible member of the tennis media. The journalist dives into the place doubles has in the pro game, and what really makes the game exciting and entertaining. And Walsh looks at Katerina Siniakova's brilliance, as she climbs up the all-time doubles ranks. Hosted by Mitch Michals. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Aziz Dougaz sits down ahead of Wimbledon 2026 qualifying to talk about his preparations, his journey to the All England Club, and his ambitions for the week ahead.

Shintaro Mochizuki reflects on his Wimbledon 2026 qualifying win and opens up on how his season has been shaping up so far. A great conversation with the Japanese star as he looks to make his mark on the grass at the All England Club.

Bernard Tomic speaks exclusively ahead of Wimbledon 2026 qualifying, opening up on what it means to be back at the All England Club, reflecting on his remarkable career and looking ahead to what comes next. A candid and fascinating conversation with one of tennis's most compelling characters.

Hugo Gaston sits down after his Wimbledon 2026 qualifying first round win to reflect on the match and share his thoughts on the week ahead. A great conversation with the talented Frenchman as he looks to push through qualifying at the All England Club.

Dane Sweeny reflects on his Wimbledon 2026 qualifying first round win and shares his thoughts on his season so far. A great conversation with the rising Australian star as he looks to push through qualifying at the All England Club.

Bernard Tomic and Paul Jubb kick off Wimbledon 2026 qualifying with wins on Day 1, while Luca Nardi and Bu cruise through their opening matches. Meanwhile, David Goffin and Francisco Comesana fall at the first hurdle. We break down all the action, key performances, and ones to watch as qualifying gets underway at the All England Club.

5 SETTER: This Week in Racket Sports, where we bring you the top five headlines across tennis, padel, pickleball, and more. Wimbledon 2026 is the center of the tennis universe this week — and the Williams Sisters are back at the All England Club. Serena and Venus have been awarded a doubles wild card, with one mystery women's singles slot still to be announced. Could Serena be eyeing a singles run too? In this episode, we cover the biggest stories shaking up the world of racket sports: 1. Williams Sisters land Wimbledon doubles wild card — and Serena hasn't ruled out singles 2. Wimbledon 2026 entry update: Wawrinka's farewell lap, Dimitrov's comeback, Evans snubbed, Chwalinska earns singles WC, and key withdrawals 3. Andy Murray coaches Jack Draper through grass season 4. Saudi Arabia unveils $40B Qiddiya tennis mega-complex 5. Tennis.com gets a digital update If you follow pro tennis, play padel or pickleball, or just want to stay in the loop with the fastest-growing sports on the planet, this is your weekly fix. Subscribe for weekly episodes covering major stories, sharp insights, and fun surprises in the world of racket sports. COMMENT BELOW What was your favorite racket story from this week?

Are you a member of our Patreon channel yet? It's the only way to get ad-free listening, daily podcasts from Tennis Unfiltered during grand slams, access to weekly bonus episodes every Friday and group chats with other Patreon members. Join the Tennis Unfiltered Supporters Club here: https://www.patreon.com/tennisunfiltered **** NB: This podcast was recorded BEFORE the Wimbledon wildcards were confirmed on Tuesday. We can only apologise. Blame the All England Club. Calvin Betton (west London), James Gray (south London) and George Bellshaw (actual Mexico) are back to go through another week of tennis news. And it really is all about wildcards. - Donna Vekic, with Dave Felgate back in tow, wins the women's title at Queen's, seeing off Emma Raducanu in her biggest final since winning the US Open five years ago - Serena Williams was back playing, in doubles for now, with Victoria Mboko, although a nasty knee injury stopped her progress and ruled the teenager out of Wimbledon - Meanwhile, Queen's defending champion Tatjana Maria had to come through qualifying for the chance to play at the west London WTA 500, after organisers handed all the WTA wildcards to Brits - Dan Evans is retiring but he is also not happy at Queen's, after they failed to give him a wildcard to the main draw... will he get one at Wimbledon? - Speaking of Wimbledon, they have announced their prize money with a 20 per cent uplift for players, but not all players... Learn more about your ad choices. Visit podcastchoices.com/adchoices

Are you a member of our Patreon channel yet? It's the only way to get ad-free listening, daily podcasts from Tennis Unfiltered during grand slams, access to weekly bonus episodes every Friday and group chats with other Patreon members. Join the Tennis Unfiltered Supporters Club here: https://www.patreon.com/tennisunfiltered **** NB: This podcast was recorded BEFORE the Wimbledon wildcards were confirmed on Tuesday. We can only apologise. Blame the All England Club. Calvin Betton (west London), James Gray (south London) and George Bellshaw (actual Mexico) are back to go through another week of tennis news. And it really is all about wildcards. - Donna Vekic, with Dave Felgate back in tow, wins the women's title at Queen's, seeing off Emma Raducanu in her biggest final since winning the US Open five years ago - Serena Williams was back playing, in doubles for now, with Victoria Mboko, although a nasty knee injury stopped her progress and ruled the teenager out of Wimbledon - Meanwhile, Queen's defending champion Tatjana Maria had to come through qualifying for the chance to play at the west London WTA 500, after organisers handed all the WTA wildcards to Brits - Dan Evans is retiring but he is also not happy at Queen's, after they failed to give him a wildcard to the main draw... will he get one at Wimbledon? - Speaking of Wimbledon, they have announced their prize money with a 20 per cent uplift for players, but not all players... Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today, the All England Club and Wimbledon announced a 20% increase in prize money compared to 2025, bringing the total prize money fund to £64.2 million. Andy Roddick talks with Deborah Jevans (Chair of the All England Lawn Tennis Club) and Jamie Baker (Tournament Director of The Championships) to understand what these decisions look like from the inside, where communication with players currently stands, and what more Wimbledon is adding for the benefit of the players.